QCLS

0.27845.95%
SA

Stephen A. Friscia

Independent Director

Mr. Stephen A. Friscia Jr. is Independent Director at Q/C Technologies, Inc. (formerly known as TNF Pharmaceuticals, Inc.) (formerly known as MyMD Pharmaceuticals, Inc.) since June 13, 2024. He is the manager and co-founder of Kipps Capital, a family office established in 2016. Previously, Mr. Friscia was a managing director and portfolio manager for multiple institutional investment and asset management firms, with several focused in small and mid-cap value equities, including Iridian Asset Management LLC, John A. Levin & Co., Inc. and Evergreen Investments LLC (Wachovia Corporation). He was a Portfolio Manager at MacKay Shields LLC. He joins the New Small Cap Value Equity Team and is a Portfolio Manager of The MainStay Funds MainStay Small Cap Value Fund. Previously, he was a Managing Director and Portfolio Manager at Bear Stearns Asset Management Inc. He was a member of the firm's fundamental small cap value equity team. Previously, Mr. Friscia joined the firm in 2006. Previously, he was a Portfolio Manager, Securities Analyst, a member of the long only investment team and a co manager of the small cap value team at BKF Asset Management, Inc. Mr. Friscia was also employed at BKF Capital Group. Prior to BKF, he served as a Portfolio Manager and Senior Analyst at Palisade Capital Management. Mr. Friscia also held positions at Evergreen Investment Management Company as a Portfolio Manager from 2002 to 2003, an Equity Research Analyst from 1998 to 2002, a Fixed Income Securities Analyst from 1995 to 1998 and an Accountant from 1993 to 1995. Mr. Friscia is a Chartered Financial Analyst. He earned a B.S. from the SUNY College at New Paltz and an M.B.A. from the Pace University.

Positions